TGFB1 and neoplasm: Park et al. showed that PEGylated liposomes encapsulated a small molecule TGF-β inhibitor together with IL-2 significantly delayed tumor growth due to the increased activity of NK cells and the infiltration of activated CD8 T cells in a B16/B6 mouse model of melanoma after intratumoral or systemic administration [166].